Select Medical Holdings Co. (NYSE:SEM) Given Consensus Rating of “Moderate Buy” by Brokerages

Shares of Select Medical Holdings Co. (NYSE:SEMGet Free Report) have received an average recommendation of “Moderate Buy” from the four analysts that are presently covering the firm, MarketBeat reports. Two investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $34.40.

Several brokerages have commented on SEM. Benchmark reiterated a “buy” rating and issued a $39.00 price target on shares of Select Medical in a research report on Friday, April 12th. StockNews.com upgraded Select Medical from a “hold” rating to a “buy” rating in a report on Friday, March 22nd.

Get Our Latest Report on Select Medical

Select Medical Stock Performance

Shares of SEM opened at $27.41 on Friday. The firm has a market capitalization of $3.52 billion, a PE ratio of 14.35, a P/E/G ratio of 1.08 and a beta of 1.37. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.32. The firm has a 50-day moving average price of $28.24 and a 200 day moving average price of $25.75. Select Medical has a 52-week low of $21.28 and a 52-week high of $33.51.

Select Medical (NYSE:SEMGet Free Report) last posted its quarterly earnings data on Friday, February 23rd. The health services provider reported $0.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.31 by $0.05. Select Medical had a net margin of 3.65% and a return on equity of 16.93%. The business had revenue of $1.66 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same period last year, the firm posted $0.22 earnings per share. The business’s revenue was up 4.9% on a year-over-year basis. On average, sell-side analysts anticipate that Select Medical will post 2.03 earnings per share for the current fiscal year.

Select Medical Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, March 13th. Shareholders of record on Friday, March 1st were paid a dividend of $0.125 per share. This represents a $0.50 dividend on an annualized basis and a dividend yield of 1.82%. The ex-dividend date of this dividend was Thursday, February 29th. Select Medical’s dividend payout ratio (DPR) is currently 26.18%.

Insider Activity

In related news, Chairman Robert A. Ortenzio sold 50,000 shares of Select Medical stock in a transaction on Monday, April 8th. The stock was sold at an average price of $29.90, for a total transaction of $1,495,000.00. Following the completion of the sale, the chairman now owns 6,689,668 shares of the company’s stock, valued at $200,021,073.20. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 19.14% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Select Medical

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. increased its stake in shares of Select Medical by 2.9% during the 4th quarter. Vanguard Group Inc. now owns 12,347,798 shares of the health services provider’s stock worth $290,173,000 after purchasing an additional 342,496 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in Select Medical by 1.1% in the fourth quarter. Dimensional Fund Advisors LP now owns 4,431,681 shares of the health services provider’s stock worth $104,147,000 after purchasing an additional 48,300 shares in the last quarter. Victory Capital Management Inc. increased its position in Select Medical by 15.7% during the fourth quarter. Victory Capital Management Inc. now owns 1,739,361 shares of the health services provider’s stock worth $40,875,000 after buying an additional 235,964 shares during the last quarter. Charles Schwab Investment Management Inc. raised its holdings in Select Medical by 5.8% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,467,109 shares of the health services provider’s stock valued at $34,477,000 after buying an additional 79,907 shares in the last quarter. Finally, Norges Bank acquired a new stake in shares of Select Medical in the fourth quarter worth about $34,320,000. Institutional investors own 89.48% of the company’s stock.

About Select Medical

(Get Free Report

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

Featured Articles

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.